Interparfums (NASDAQ:IPAR) and BioHarvest Sciences (NASDAQ:BHST) Financial Analysis

Interparfums (NASDAQ:IPAR) and BioHarvest Sciences (NASDAQ:BHST) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Interparfums and BioHarvest Sciences, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Interparfums	1	5	2	0	2.12
BioHarvest Sciences	1	0	2	0	2.33

Interparfums currently has a consensus price target of $125.29, suggesting a potential downside of 7.57%. BioHarvest Sciences has a consensus price target of $6.50, suggesting a potential upside of 308.81%. Given BioHarvest Sciences’ stronger consensus rating and higher probable upside, analysts clearly believe BioHarvest Sciences is more favorable than Interparfums.

Profitability

This table compares Interparfums and BioHarvest Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Interparfums	11.17%	15.21%	10.85%
BioHarvest Sciences	-31.21%	-58.30%	-25.60%

Earnings and Valuation

This table compares Interparfums and BioHarvest Sciences”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Interparfums	$1.49 billion	2.92	$168.39 million	$5.31	25.53
BioHarvest Sciences	$34.51 million	0.90	-$11.14 million	($0.52)	-3.06

Interparfums has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Interparfums has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Comparatively, BioHarvest Sciences has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500.

Institutional & Insider Ownership

55.6% of Interparfums shares are held by institutional investors. 43.6% of Interparfums shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Interparfums beats BioHarvest Sciences on 11 of the 13 factors compared between the two stocks.

About Interparfums

Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. It operates in two segments, European Based Operations and United States Based Operations. The company offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Emanual Ungaro, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, Ungaro, and Roberto Cavalli brands, as well as French Connection, Intimate, and Dunhill, Lacoste names. It sells its products to department stores, perfumeries, specialty stores, duty free shops, and domestic and international wholesalers, and distributors, as well as through e-commerce. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1982 and is headquartered in New York, New York.

About BioHarvest Sciences

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.